Market cap
$150 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
33.6
P/B Ratio
1.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$3 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
--
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
11,500,000
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
LAVA Medtech Acquisition Corp (LVAC)
| 2.5 | 0.0 | 0.9 | 4.3 | -- | -- | -- |
|
BSE Sensex*
| -9.1 | -1.2 | 2.9 | -3.6 | 5.7 | 6.2 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
LAVA Medtech Acquisition Corp (LVAC)
|
10.4 | 149.9 | 0.0 | 4.5 | -- | 4 | 33.6 | 1.3 |
| 10.3 | 201.9 | 0.0 | 1.0 | -- | 0.6 | -- | 0.0 | |
| 13.9 | 98.5 | 0.0 | -4.9 | -- | -3.7 | -- | 1.3 | |
| 28.7 | 79.0 | 0.0 | -8.6 | -- | -25.1 | -- | 0.0 | |
| 10.2 | 131.3 | 0.0 | 1.2 | -- | -3.7 | -- | 1.3 | |
| 8.3 | 86.6 | 0.0 | -3.6 | -- | -3.2 | -- | 1.3 | |
| 10.5 | 253.6 | 0.0 | 6.3 | -- | 3.3 | 95.8 | 0.0 | |
| 10.4 | 289.0 | 0.0 | 7.3 | -- | 3.3 | 41.6 | 1.3 | |
| 10.2 | 452.3 | 0.0 | 18.2 | -- | 5.4 | 93 | 1.3 | |
| 6.1 | 78.5 | 0.0 | 0.9 | -- | 1.4 | -- | 1.3 |
Shareholding Pattern
View DetailsAbout LAVA Medtech Acquisition Corp (LVAC)
LAVA Medtech Acquisition Corp. does not have significant operations. It intends to acquire assets and businesses through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or... more businesses. The company was incorporated in 2021 and is based in Waltham, Massachusetts. LAVA Medtech Acquisition Corp. is a subsidiary of LAVA Medtech Sponsor LP. Read more
-
CEO & Director
Dr. Anthony Natale M.B.A., M.D.
-
CEO & Director
Dr. Anthony Natale M.B.A., M.D.
-
Headquarters
Waltham, MA
-
Website
--
FAQs for LAVA Medtech Acquisition Corp (LVAC)
What is the current share price of LAVA Medtech Acquisition Corp (LVAC) Today?
The share price of LAVA Medtech Acquisition Corp (LVAC) is $10.44 (NASDAQ) as of 19-May-2023 09:30 EDT. LAVA Medtech Acquisition Corp (LVAC) has given a return of 4.3% in the last 1 years.
What is the current PB & PE ratio of LAVA Medtech Acquisition Corp (LVAC)?
The P/E ratio of LAVA Medtech Acquisition Corp (LVAC) is 33.65 times as on 19-May-2023.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
-- |
-- |
2021 |
-- |
-- |
2022 |
-- |
-- |
2021 |
-- |
-- |
What is the 52 Week High and Low of LAVA Medtech Acquisition Corp (LVAC)?
The 52-week high and low of LAVA Medtech Acquisition Corp (LVAC) are Rs -- and Rs -- as of 31-Aug-2026.
What is the market cap of LAVA Medtech Acquisition Corp (LVAC)?
LAVA Medtech Acquisition Corp (LVAC) has a market capitalisation of $ 150 Mln as on 19-May-2023. As per SEBI classification, it is a Small Cap company.
Should I invest in LAVA Medtech Acquisition Corp (LVAC)?
Before investing in LAVA Medtech Acquisition Corp (LVAC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.